Skip to main content
Log in

Reduction of the reinforcing effectiveness of cocaine by continuous d-amphetamine treatment in rats: importance of active self-administration during treatment period

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Continuous administration of d-amphetamine has shown promise as a treatment for psychostimulant addiction. In rodent studies, constant infusion of d-amphetamine (5 mg/kg/day) has been shown to reduce cocaine-reinforced responding in the dose range of 0.19–0.75 mg/kg/inf.

Objectives

The present study tested whether these effects were a reflection of pharmacological interactions between d-amphetamine and cocaine or if they resulted from associative learning mechanisms

Methods

After stable progressive ratio (PR) baselines were established, rats were implanted with subcutaneous osmotic minipumps filled with either d-amphetamine (5 mg/kg/day—groups 1 and 2) or saline (group 3). During the treatment period, groups 1 and 3 self-administered cocaine at a dose that was previously shown to produce the most robust effects in combination with d-amphetamine treatment (0.19 mg/kg/inf), while group 2 received passive cocaine infusions.

Results

In replication of previous studies, d-amphetamine treatment resulted in a significant (35 %) decrease in breakpoints relative to saline controls. By contrast, no reductions in breakpoints were observed in animals that received passive cocaine infusions during the treatment period (group 2).

Conclusions

Active self-administration of cocaine during the treatment period appears to be an important factor in reducing cocaine-reinforced breakpoints. These findings suggest learning mechanisms are involved in the therapeutic effects of continuous d-amphetamine, and pharmacological interaction mechanisms such as cross-tolerance cannot completely account for the observed decreases in cocaine seeking.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Charnaud B, Griffiths V (1998) Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison. Drug Alcohol Depend 52:79–84

    Article  CAS  PubMed  Google Scholar 

  • Chiodo KA, Roberts DCS (2009) Decreased reinforcing effects of cocaine following 2 weeks of continuous d-amphetamine treatment in rats. Psychopharmacology 206:447–456

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chiodo KA, Lack CM, Roberts DCS (2008) Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous d-amphetamine treatment in rats. Psychopharmacology 200:465–473

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Czoty PW, Martelle JL, Nader MA (2010) Effects of chronic d-amphetamine on the reinforcing strength of cocaine in rhesus monkeys. Psychopharmacology 209:375–382

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Czoty PW, Gould RW, Martelle JL, Nader MA (2011) Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys. Neuropsychopharmacology 36:539–547

    Article  CAS  PubMed  Google Scholar 

  • Fleming PM, Roberts D (1994) Is the prescription of amphetamine justified as a harm reduction measure? J R Soc Health 114:127–131

    Article  CAS  PubMed  Google Scholar 

  • Foltin RW, Evans SM (1999) The effects of d-amphetamine on intake of food and a sweet fluid containing cocaine. Pharmacol Biochem Behav 62:457–464

    Article  CAS  PubMed  Google Scholar 

  • Galloway GP, Buscemi R, Coyle JR, Flower K, Siegrist JD, Fiske LA, Baggott MJ, Li L, Polcin D, Chen CYA, Mendelson J (2010) A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther 89(2):276–282

    Article  PubMed Central  PubMed  Google Scholar 

  • Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D, Moeller FG (2001) Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 21:522–526

    Article  CAS  PubMed  Google Scholar 

  • Grabowski J, Rhoades H, Stotts A, Cowan K, Kopecky C, Dougherty A, Moeller FG, Hassan S, Schmitz J (2004) Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29:969–981

    Article  CAS  PubMed  Google Scholar 

  • Longo M, Wickes W, Smout M, Harrison S, Cahill S, White JM (2009) Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction 105:146–154

    Article  PubMed  Google Scholar 

  • Mansbach RS, Balster RL (1993) Effects of mazindol on behavior maintained or occasioned by cocaine. Drug Alcohol Depend 31:183–191

    Article  CAS  PubMed  Google Scholar 

  • Mendelson JH, Mello NK (1996) Management of cocaine abuse and dependence. New Engl J Med 334:965–972

    Article  CAS  PubMed  Google Scholar 

  • Negus SS (2003) Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology 28:909–931

    Google Scholar 

  • Negus SS, Mello NK (2003a) Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology 167:324–332

    CAS  PubMed  Google Scholar 

  • Negus SS, Mello NK (2003b) Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend 70:39–52

    Article  CAS  PubMed  Google Scholar 

  • Peltier RL, Li DH, Lytle D, Taylor CM, Emmet-Oglesby MW (1996) Chronic d-amphetamine or methamphetamine produces cross-tolerance to the discriminative and reinforcing stimulus effects of cocaine. J Pharmacol Exp Ther 277:212–218

    CAS  PubMed  Google Scholar 

  • Preti A (2007) New developments in the pharmacotherapy of cocaine abuse. Addict Biol 12:133–151

    Article  CAS  PubMed  Google Scholar 

  • Ray LA, Hutchison KE (2007) Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 64(9):1069–1077

    Article  CAS  PubMed  Google Scholar 

  • Ray LA, Krull JL, Leggio L (2010) The effects of naltrexone among alcohol non-abstainers: results from the COMBINE study. Front Psychiatry 1(26):1–6

    Google Scholar 

  • Richardson NR, Roberts DCS (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1–11

    Article  CAS  PubMed  Google Scholar 

  • Roberts DCS, Morgan D, Liu Y (2007) How to make a rat addicted to cocaine. Prog Neuropsychopharmacol Biol Psychiatry 31(8):1614–1624

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rosenthal RN (2006). Current and future drug therapies for alcohol dependence. Journal of Clinical Psychopharmacology, 26(6) Suppl 1:S20–S29.

    Google Scholar 

  • Rush CR, Stoops WW, Hays LR (2009) Cocaine effects during d-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. Drug Alcohol Depend 99:261–271

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rush CR, Stoops WW, Sevak RJ, Hays LR (2010) Cocaine choice in humans during d-amphetamine maintenance. J Clin Psychopharmacol 30(2):152–159

    Article  CAS  PubMed  Google Scholar 

  • Shearer J (2008) The principles of agonist pharmacotherapy for psychostimulant dependence. Drug Alcohol Rev 27:301–308

    Article  PubMed  Google Scholar 

  • Shearer J, Wodak A, Van BI, Mattick RP, Lewis J (2003) Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 98:1137–1141

    Article  PubMed  Google Scholar 

  • Vocci FJ, Elkashef A (2005) Pharmacotherapy and other treatments for cocaine abuse and dependence. Curr Opin Psychiatry 18:265–270

    Article  PubMed  Google Scholar 

  • Vocci FJ, Ling W (2005) Medications development: successes and challenges. Pharmacol Ther 108:94–108

    Article  CAS  PubMed  Google Scholar 

  • Vocci FJ, Acri J, Elkashef A (2005) Medication development for addictive disorders: the state of the science. Am J Psychiatry 162:1432–1440

    Article  PubMed  Google Scholar 

  • White R (2000) Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation. Addiction 95:229–238

    Article  CAS  PubMed  Google Scholar 

  • Wright C, Moore RD (1990) Disulfiram treatment of alcoholism. Am J Med 88(6):647–655

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the NIH-NIDA research grants R01 DA14030 and P50 DA06634

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Benjamin A. Zimmer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zimmer, B.A., Chiodo, K.A. & Roberts, D.C.S. Reduction of the reinforcing effectiveness of cocaine by continuous d-amphetamine treatment in rats: importance of active self-administration during treatment period. Psychopharmacology 231, 949–954 (2014). https://doi.org/10.1007/s00213-013-3305-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-013-3305-4

Keywords

Navigation